PEAK6 Investments’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-68
Closed -$2K 5098
2021
Q2
$2K Buy
+68
New +$1.66K ﹤0.01% 4895
2020
Q4
Sell
-1,753
Closed -$22.2K 4524
2020
Q3
$21K Sell
1,753
-6,647
-79% -$63.1K ﹤0.01% 4128
2020
Q2
$85K Buy
+8,400
New +$86.6K ﹤0.01% 3867
2019
Q1
Sell
-7,823
Closed -$157K 3773
2018
Q4
$157K Buy
7,823
+5,900
+307% +$122K ﹤0.01% 3181
2018
Q3
$42K Buy
+1,923
New +$42.7K ﹤0.01% 3795

Other funds holding ANGO

PEAK6 Investments's ANGO Position: Q3 2021 in Review

PEAK6 Investments sold out of AngioDynamics (ANGO) in Q3 2021, closing a stake of 68 shares — an estimated $2K sold.

PEAK6 Investments first reported a position in ANGO in Q3 2018 and held it in 5 quarters. The position peaked at $157K in Q4 2018. 156 funds tracked by Wall St. Rank hold ANGO as of Q3 2021.

  • PEAK6 Investments reported no remaining AngioDynamics position as of Q3 2021 after selling out during the quarter.
  • PEAK6 Investments sold 68 AngioDynamics shares in Q3 2021, an estimated $2K.
  • PEAK6 Investments first reported a position in AngioDynamics in Q3 2018 and held it in 5 quarters.
  • PEAK6 Investments's AngioDynamics position peaked at $157K in Q4 2018.
  • 156 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2021.

Based on PEAK6 Investments's 13F filing for Q3 2021, filed 12 Nov 2021.